Silo Pharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SILO research report →
About the company
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS).
- CEO
- Eric Weisblum
- IPO
- 2021
- Employees
- 3
- HQ
- Sarasota, FL, US
Price Chart
- Market Cap
- $5.59M
- P/E
- -0.83
- P/S
- 77.54
- P/B
- 0.99
- EV/EBITDA
- -0.35
- Div Yield
- 0.00%
- Gross Margin
- -328.69%
- Op Margin
- -6631.16%
- Net Margin
- -6717.40%
- ROE
- -88.41%
- ROIC
- -75.73%
- Revenue
- $72.10K · 0.00%
- Net Income
- $-4,227,698 · 3.76%
- EPS
- $-7.50 · 57.98%
- Op Income
- $-4,280,662
- FCF YoY
- -21.58%
- 52W High
- $15.15
- 52W Low
- $3.31
- 50D MA
- $6.25
- 200D MA
- $6.60
- Beta
- 0.75
- Avg Volume
- 294.96K
Get TickerSpark's AI analysis on SILO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 15, 25 | Weisblum Eric | buy | 2,500 |
| Dec 15, 25 | Weisblum Eric | buy | 2,500 |
| Nov 21, 25 | Weisblum Eric | buy | 1,000 |
| Nov 20, 25 | Weisblum Eric | buy | 1,000 |
| Nov 19, 25 | Weisblum Eric | buy | 4,500 |
| Nov 18, 25 | Weisblum Eric | buy | 7,500 |
| May 27, 25 | Weisblum Eric | buy | 10,000 |
| May 23, 25 | Linsley Wayne | other | 50,000 |
| May 23, 25 | Munoz Kevin | other | 50,000 |
| May 23, 25 | Ryweck Daniel E. | other | 50,000 |
Our SILO coverage
Recent articles, reports, and earnings notes.
No research on SILO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SILO report →Similar companies
Peers in the same neighborhood.